Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Organization for Rare Disorders"


3 mentions found


This report is from today's CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. The tech-centric Nasdaq Composite remained flat, while the Dow Jones Industrial Average had its best week since May, rising 1.45%. The yield on the 10-year Treasury ticked higher and U.S. oil prices rose 2.9% for the week. [PRO] Comeback stocksThe S&P 500 has soared to record levels, fueled by the AI boom, but not all stocks are riding the wave.
Persons: JPMorgan Chase, Goldman Sachs, Tesla, Elon Musk, Musk, Tim Lugo, William Blair's Organizations: CNBC, Nvidia, Microsoft, Apple, Nasdaq, Dow Jones, Citigroup, JPMorgan, Bank of America, Apple Intelligence, Union, Therapeutics, FDA, Organization for Rare Disorders, Nike, Starbucks Locations: U.S
Read previewCéline Dion says the symptoms of her stiff-person syndrome can be easily triggered by almost anything, including laughter. Walking wobbly," Dion told Kotb. Related storiesThe "My Heart Will Go On" singer first announced that she had been diagnosed with stiff-person syndrome in December 2022. There is no cure for stiff-person syndrome, but there are ways for patients to manage their condition , including through medication and therapy. AdvertisementIn April, Dion told Vogue France that she goes to therapy five days a week and trains "like an athlete" as part of her treatment plan.
Persons: , Dion, Hoda Kotb, Kotb, Irene Taylor Brodsky, Celine Dion, Taylor, cramp, Brodsky, Céline Dion Organizations: Service, NBC, Business, National Institute of Neurological Disorders, Organization for Rare Disorders, Vogue France
The Food and Drug Administration on Wednesday approved an RSV vaccine produced by GlaxoSmithKline for use on adults ages 60 and older. London-based GSK during an earnings presentation last week said it has "millions" of doses of the RSV vaccine ready to ship. In March, an independent panel of advisors to the FDA recommended GSK's RSV vaccine based on data from a phase three trial on older adults. A 78-year-old woman in Japan was diagnosed with Guillain-Barre syndrome nine days after receiving GSK's vaccine, according to an FDA briefing document. The FDA flagged the disorder as a potential safety issue with Pfizer's RSV vaccine for older adults.
Total: 3